|
ABCD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.37754260723477E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.83869594497332E-11 |
| Normal-vs-Stage2 |
2.64410000005988E-07 |
| Normal-vs-Stage3 |
4.11659595300762E-11 |
| Normal-vs-Stage4 |
2.61720000116483E-08 |
| Stage1-vs-Stage2 |
8.587800E-01 |
| Stage1-vs-Stage3 |
2.026600E-01 |
| Stage1-vs-Stage4 |
1.202770E-01 |
| Stage2-vs-Stage3 |
4.702000E-01 |
| Stage2-vs-Stage4 |
4.134400E-01 |
| Stage3-vs-Stage4 |
7.442800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29918298341636E-12 |
| Normal-vs-AfricanAmerican |
7.35522753814166E-13 |
| Normal-vs-Asian |
4.422700E-04 |
| Caucasian-vs-AfricanAmerican |
7.547800E-01 |
| Caucasian-vs-Asian |
8.547200E-01 |
| AfricanAmerican-vs-Asian |
7.087000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.39692768042732E-13 |
| Normal-vs-Female |
9.14729958445548E-10 |
| Male-vs-Female |
4.032400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.1019965202338E-11 |
| Normal-vs-Extreme_Weight |
1.62792002100787E-12 |
| Normal-vs-Obese |
1.1895999996181E-07 |
| Normal-vs-Extreme_Obese |
1.542030E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.981400E-01 |
| Normal_Weight-vs-Obese |
3.580200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.683900E-02 |
| Extreme_Weight-vs-Obese |
1.904250E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.273700E-02 |
| Obese-vs-Extreme_Obese |
4.900000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.57199999964541E-07 |
| Normal-vs-Age(41-60Yrs) |
1.14990239552526E-11 |
| Normal-vs-Age(61-80Yrs) |
3.91686683087755E-13 |
| Normal-vs-Age(81-100Yrs) |
1.39620000005891E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.371400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.863200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.874400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.101800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.286000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.973000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62503344114384E-12 |
| Normal-VS-Type2 PRCC |
4.70030000032651E-07 |
| Normal-VS-KIRP CIMP |
5.57650003951693E-09 |
| Normal-VS-Unclassified PRCC |
1.71259999515172E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.020800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.516100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.994600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.957900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.100000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.338000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17139639602237E-11 |
| Normal-vs-N1 |
6.9922956313917E-12 |
| Normal-vs-N2 |
5.62290000000187E-05 |
| N0-vs-N1 |
4.038000E-01 |
| N0-vs-N2 |
5.607200E-01 |
| N1-vs-N2 |
8.026200E-01 |
|
|
